Table: Taiko Pharmaceutical -2020 parent results
Feb 12 (Reuters)-
Taiko Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Mar 31, 2020 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 17.09 14.46
(+45.8 pct)
Operating 5.62 3.70
(+91.2 pct)
Recurring 5.47 3.52
(+97.0 pct)
Net 3.87 2.36
(+76.8 pct)
EPS 89.57 yen 55.31 yen
EPS Diluted 89.21 yen 55.09 yen
Ann Div 25.00 yen 50.00 yen 20.00 yen
-Q2 Div 7.00 yen 10.00 yen 7.00 yen
-Q4 Div 18.00 yen 40.00 yen 13.00 yen
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T